Themis Medicare Limited — Others, 01-08-2025: Appointment

Themis Medicare's board has approved its financial results for the quarter ended June 30, 2025, reporting a standalone loss of Rs 15.37 crore on revenue of Rs 97.58 crore and a consolidated loss of Rs 14.22 crore on revenue of Rs 97.57 crore. The company made key leadership appointments: Ms. Neha Thakore as Independent Director and Mr. Viraj Save as Executive President – Sales & Marketing. Strategically, the proposed merger with Gujarat Themis Biosyn has been withdrawn to sharpen focus on the core domestic formulations business. The record date for the FY25 final dividend is September 5. Additionally, Rs 1.29 crore in receivables/advances for its dissolved UK subsidiary, Carpo Medicals, has been provided for.